Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DODECYL GALLATE CRS (30 MG)

DODECYL GALLATE CRS (30 MG)

1166-52-5

DISCOVER
ISRADIPINE CRS (125 MG)

ISRADIPINE CRS (125 MG)

75695-93-1

DISCOVER
ISRADIPINE IMPURITY D CRS (5 MG)

ISRADIPINE IMPURITY D CRS (5 MG)

NA

DISCOVER
OCTYL GALLATE CRS (30 MG)

OCTYL GALLATE CRS (30 MG)

1034-01-1

DISCOVER
Primidone for peak identification CRS, 10mg

Primidone for peak identification CRS, 10mg

125-33-7

DISCOVER
RISPERIDONE FOR SYSTEM SUITABILITY CRS (20 MG)

RISPERIDONE FOR SYSTEM SUITABILITY CRS (20 MG)

106266-06-2

DISCOVER
Sestamibi labelling kit CRS, 22mg

Sestamibi labelling kit CRS, 22mg

NA

DISCOVER
THIAMAZOLE IMPURITY A CRS (50MG)

THIAMAZOLE IMPURITY A CRS (50MG)

NA

DISCOVER
THIAMAZOLE IMPURITY C CRS (40MG)

THIAMAZOLE IMPURITY C CRS (40MG)

NA

DISCOVER
COLESTYRAMINE CRS (10 MG)

COLESTYRAMINE CRS (10 MG)

11041-12-6

DISCOVER
FLUSPIRILENE IMPURITY C CRS (10 MG)

FLUSPIRILENE IMPURITY C CRS (10 MG)

NA

DISCOVER
DIPIVEFRINE HYDROCHLORIDE CRS(100 MG)

DIPIVEFRINE HYDROCHLORIDE CRS(100 MG)

64019-93-8

DISCOVER